Results advises SEP on its significant investment in Dotmatics
- Service: Equity Fundraising, M&A
- Sector: Technology, Healthcare
- Sub Sector: Enterprise SaaS, Healthcare IT
- Engagement Type: Buy Side
Results is delighted to announce that it has advised Scottish Equity Partners (SEP) on its significant investment into Dotmatics.
Scottish Equity Partners (SEP) has completed a significant investment in Dotmatics. The company, founded in 2005, is a leading global scientific informatics software provider delivering enterprise solutions tailored to the modern, highly collaborative and mobile scientific environments. Dotmatics provides solutions for pharmaceutical, biotechnology, academia, food and beverage, oil and gas, and agrochemical industries. The funding will enable Dotmatics to continue its investment into product innovation and customer success, as well as to strengthen operations in each of its key geographies.
We chose Results to advise us on this investment as their network and experience spans both pharmaceutical research and enterprise software. Deep domain knowledge in each of these fields was invaluable in allowing us to reach a successful conclusion.
Partner at SEP